Improving medication management to reduce dementia risk in African Americans and Latinos
Official title: Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos
Funded at Pilltrax Systems LLC · NIH-10610975 · Data updated 2026-11-12
This study is all about helping African Americans and Latinos take their medications regularly to better manage conditions like high blood pressure and diabetes, which can lower the risk of developing Alzheimer's disease and related dementias, using tools like a smart pill dispenser and text reminders.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pilltrax Systems LLC NIH-funded |
| Lab location | 1 site (Brighton, UNITED STATES) |
| Project start | September 18, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $299,553 |
| NIH project number | 1R43AG081035-01 |
| Project ID | NIH-10610975 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African American and Latino individuals who are at risk for Alzheimer's disease and related dementias due to hypertension or diabetes.
✕Less likely to help
Patients who do not have hypertension or diabetes, or those who are not part of the African American or Latino communities may not benefit from this research.
What this research studies
This research focuses on enhancing medication adherence among African Americans and Latinos to better manage risk factors for Alzheimer's disease and related dementias (ADRD). It aims to implement a medication management service that includes an electronic pill dispenser, SMS notifications for medication adherence, and a provider portal for tracking adherence data. By addressing the low adherence rates to hypertension and diabetes medications, the project seeks to lower the risk of developing ADRD in these populations. The approach is designed to be proactive and supportive, helping patients stay on track with their medications.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of Alzheimer's disease and related dementias among African Americans and Latinos.
How similar studies have gone: Previous research has shown that improving medication adherence can lead to better health outcomes, indicating that this approach has potential for success.
Where this research is happening
-
Pilltrax Systems LLC
Brighton, United States Active
Researchers
- Principal investigator: Ramsey, Alvin — Pilltrax Systems LLC
- Study coordinator: Ramsey, Alvin
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
ALS risk factors in a long-term ALS study
A long-term ALS study is looking at which factors may influence disease risk and progression in people living with ALS.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetic, behavior, and vascular data
Aims to predict Alzheimer’s disease risk in middle-aged South Asians by combining genetic, lifestyle, and vascular information to catch early changes before dementia develops.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetics, behavior, and vascular data
Aimed at people 21 and older, this project looks at how biology, behavior, and blood vessel health together may signal the early risk of Alzheimer’s disease and related dementias in South Asians.
-
Understanding how risk factors affect progression of cirrhosis and response to statins in patients with cirrhosis
This project follows people with cirrhosis to see what factors speed up their liver disease and whether statin medicines help prevent worsening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.